Palatin Technologies
PTN
#9955
Rank
โ‚น3.26 B
Marketcap
โ‚น1,920
Share price
-7.04%
Change (1 day)
2,392.61%
Change (1 year)

Palatin Technologies (PTN) - Total debt

Total debt on the balance sheet as of March 2025 : โ‚น23.55 Million

According to Palatin Technologies's latest financial reports the company's total debt is โ‚น23.55 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Palatin Technologies - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-06-30โ‚น49.21 M-42.92%
2023-06-30โ‚น86.22 M-5.36%
2022-06-30โ‚น91.11 M-2.18%
2021-06-30โ‚น93.14 M-2.89%
2020-06-30โ‚น95.9 M317.91%
2019-06-30โ‚น22.95 M-94.66%
2018-06-30โ‚น0.42 B-52.88%
2017-06-30โ‚น0.91 B-30.76%
2016-06-30โ‚น1.31 B110.42%
2015-06-30โ‚น0.62 B
2014-06-30N/A-100%
2013-06-30โ‚น1.18 M-49.39%
2012-06-30โ‚น2.34 M-31.9%
2011-06-30โ‚น3.43 M118.21%
2010-06-30โ‚น1.57 M-72.93%
2009-06-30โ‚น5.82 M-64.76%
2008-06-30โ‚น16.51 M-17.18%
2007-06-30โ‚น19.94 M36.12%
2006-06-30โ‚น14.64 M1015.03%
2005-06-30โ‚น1.31 M-54.95%
2004-06-30โ‚น2.91 M-76.21%
2003-06-30โ‚น12.25 M
2001-06-30โ‚น1.3 M
1999-06-30โ‚น86.78 M126.88%
1998-06-30โ‚น38.25 M-40.73%
1997-06-30โ‚น64.52 M-43.52%
1996-06-30โ‚น0.11 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
MediciNova
MNOV
โ‚น27.11 M 15.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น38.48 B 163,274.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น55.71 B 236,460.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น40.51 B 171,891.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น4.113 T 17,464,242.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น18.64 B 79,074.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น2.931 T 12,444,412.24%๐Ÿ‡ฌ๐Ÿ‡ง UK